Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$235.67 +2.66 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Cost of Revenue (2010 - 2026)

Updated

Jazz Pharmaceuticals (JAZZ) posted Cost of Revenue of $116.4 million for Q2 2026, up 0.1% from $116.3 million a year earlier but down 13.2% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Cost of Revenue (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Jazz Pharmaceuticals was $532.91 million, up 15.5% year-over-year; for FY2025, it was $503.3 million, up 12.9% from FY2024.

  • Annual Cost of Revenue shows a five-year compound annual growth rate of 27.6% (FY2020 to FY2025).
  • In prior years, Jazz Pharmaceuticals' Cost of Revenue was $445.71 million in FY2024 (+2.3%), $435.58 million in FY2023 (-19.4%), $540.52 million in FY2022 (+22.6%) and $440.76 million in FY2021 (+196.0%).
  • Quarterly Cost of Revenue has run from a low of $95.49 million in Q1 2024 to a high of $167.36 million in Q4 2022 over five years.
  • On a year-over-year basis, Cost of Revenue has increased in each of the last nine quarters, with growth averaging 13.5% over the last eight quarters.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q3 2021, with growth of 245.0%; the weakest was Q4 2023, with a decline of 35.9%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $134.1 million (Q1 2026), $153.53 million (Q4 2025) and $128.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Jazz Pharmaceuticals 15.30 Bn 9.12 Bn 1.09 Bn 116.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 116.40 Mn
Mar 31, 2026 134.10 Mn
Dec 31, 2025 153.53 Mn
Sep 30, 2025 128.88 Mn
Jun 30, 2025 116.30 Mn
Mar 31, 2025 104.60 Mn
Dec 31, 2024 128.71 Mn
Sep 30, 2024 111.61 Mn
Jun 30, 2024 109.90 Mn
Mar 31, 2024 95.49 Mn
Dec 31, 2023 107.24 Mn
Sep 30, 2023 102.15 Mn
Jun 30, 2023 97.54 Mn
Mar 31, 2023 128.64 Mn
Dec 31, 2022 167.36 Mn
Sep 30, 2022 133.66 Mn
Jun 30, 2022 124.21 Mn
Mar 31, 2022 115.28 Mn
Dec 31, 2021 136.15 Mn
Sep 30, 2021 145.22 Mn
API Access

Jazz Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=JAZZ&period=max&api_key=YOUR_API_KEY